Guy Gery P, Machlin Steven R, Ekwueme Donatus U, Yabroff K Robin
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.
Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville.
Am J Prev Med. 2015 Feb;48(2):183-187. doi: 10.1016/j.amepre.2014.08.036. Epub 2014 Nov 10.
Skin cancer, the most common cancer in the U.S., is a major public health problem. The incidence of nonmelanoma and melanoma skin cancer is increasing; however, little is known about the economic burden of treatment.
To examine trends in the treated prevalence and treatment costs of nonmelanoma and melanoma skin cancers.
This study used data on adults from the 2002-2011 Medical Expenditure Panel Survey full-year consolidated files and information from corresponding medical conditions and medical event files to estimate the treated prevalence and treatment cost of nonmelanoma skin cancer, melanoma skin cancer, and all other cancer sites. Analyses were conducted in January 2014.
The average annual number of adults treated for skin cancer increased from 3.4 million in 2002-2006 to 4.9 million in 2007-2011 (p<0.001). During this period, the average annual total cost for skin cancer increased from $3.6 billion to $8.1 billion (p=0.001), representing an increase of 126.2%, while the average annual total cost for all other cancers increased by 25.1%. During 2007-2011, nearly 5 million adults were treated for skin cancer annually, with average treatment costs of $8.1 billion each year.
These findings demonstrate that the health and economic burden of skin cancer treatment is substantial and increasing. Such findings highlight the importance of skin cancer prevention efforts, which may result in future savings to the healthcare system.
皮肤癌是美国最常见的癌症，是一个重大的公共卫生问题。非黑色素瘤和黑色素瘤皮肤癌的发病率正在上升；然而，对于治疗的经济负担却知之甚少。
研究非黑色素瘤和黑色素瘤皮肤癌的治疗患病率及治疗费用趋势。
本研究使用了2002 - 2011年医疗支出面板调查全年合并文件中的成人数据，以及相应医疗状况和医疗事件文件中的信息，以估计非黑色素瘤皮肤癌、黑色素瘤皮肤癌和所有其他癌症部位的治疗患病率及治疗费用。分析于2014年1月进行。
接受皮肤癌治疗的成年人年均数量从2002 - 2006年的340万增加到2007 - 2011年的490万（p<0.001）。在此期间，皮肤癌的年均总成本从36亿美元增加到81亿美元（p = 0.001），增长了126.2%，而所有其他癌症的年均总成本增长了25.1%。在2007 - 2011年期间，每年有近500万成年人接受皮肤癌治疗，年均治疗费用为81亿美元。
这些发现表明，皮肤癌治疗的健康和经济负担巨大且在增加。这些发现凸显了皮肤癌预防工作的重要性，这可能会为医疗保健系统带来未来的节省。
